セッション情報

一般演題 (示説)

第53回・2015年・京都
一般演題 (示説)
示説17
Stomach:Esophageal and Gastric Cancer
開催回
第53回・2015年・京都

Lysine-specific demethylase-1 regulates glycolytic pathway in esophageal cancer

演題番号 : P17-1

Kosumi Keisuke:1、Baba Yoshifumi:1、Ishimoto Takatsugu:1、Harada Kazuto:1、Nakamura Kenichi:1、Ohuchi Mayuko:1、Kiyozumi Yuki:1、Izumi Daisuke:1、Tokunaga Ryuma:1、Kurashige Junji:1、Iwatsuki Masaaki:1、Sakamoto Yasuo:1、Miyamoto Yuji:1、Yoshida Naoya:1、Baba Hideo:1

1:Department of Gastroenterological Surgery, University Hospital, Kumamoto University

Lysine-specific demethylase-1 regulates glycolytic pathway in esophageal cancer

An analysis on the usefulness of ALDH in esophageal squamous cell carcinoma

演題番号 : P17-2

Murakami Kentaro:1、Akutsu Yasunori:1、Usui Akihiro:1、Kano Masayuki:1、Suito Hiroshi:1、Takahashi Masahiko:1、Matsumoto Yasunori:1、Otsuka Ryota:1、Matsubara Hisahiro:1

1:Department of Frontier Surgery, Faculty of Medicine, Chiba University

An analysis on the usefulness of ALDH in esophageal squamous cell carcinoma

Association between genetic polymorphisms in CTTN and susceptibility to gastric cancer

演題番号 : P17-3

Kang Dongbaek:1,2、Kim Keunyoung:1,2、Park Woncheol:1,2、Chae Soocheon:2,3、Lee Jeonkyun:1,2

1:Department of Surgery, University of Wonkwang、2:Digestive Disease Research Institute、3:Department of Pathology, University of Wonkwang

Association between genetic polymorphisms in CTTN and susceptibility to gastric cancer

Overexpression of PBK contributes to malignant outcome in gastric cancer

演題番号 : P17-4

Ohashi Takuma:1、Komatsu Shuhei:1、Ichikawa Daisuke:1、Miyamae Mahito:1、Okajima Wataru:1、Imamura Taisuke:1、Kosuga Toshiyuki:1、Konishi Hirotaka:1、Shiozaki Atushi:1、Fujiwara Hitoshi:1、Okamoto Kazuma:1、Tsuda Hitoshi:2,3、Otsuji Eigo:1

1:Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine、2:Department of Pathology, National Cancer Center Hospital、3:Department of Pathology, National Defense Medical College

Overexpression of PBK contributes to malignant outcome in gastric cancer

Stromal TGFBI expression is associated with poor prognosis in esophageal cancer and gastric cancer, and would be a novel therapeutic target of the malignancies

演題番号 : P17-5

Yokobori Takehiko:1、Ozawa Daigo:2、Altan Bolag:2、Ogata Kyoichi:2、Miyazaki Tatsuya:2、Asao Takayuki:3、Kuwano Hiroyuki:2、Nishiyama Masahiko:1

1:Department of Molecular Pharmacology and Oncology, Faculty of Medicine, Gunma University、2:Department of General Surgical Science, Faculty of Medicine, Gunma University、3:Department of Oncology Clinical Development, Faculty of Medicine, Gunma University

Stromal TGFBI expression is associated with poor prognosis in esophageal cancer and gastric cancer, and would be a novel therapeutic target of the malignancies

PTB1-associated miR -133b regulates the Warburg effect in gastric cancer

演題番号 : P17-6

Sugiyama Tarou:1、Akao Yukihiro:2、Tanahashi Toshiyuki:1、Mori Ryutarou:1、Tanaka Yoshihiro:1、Okumura Naoki:1、Yamaguchi Kazuya:1、Futamura Manabu:1、Yoshida Kazuhiro:1

1:Surgical Oncology, Graduate School of Medicine, Gifu University、2:Drug Discovery and Medical Infomation Sciences, Gifu University

<i>PTB1</i>-associated miR -133b regulates the Warburg effect in gastric cancer

Withdrawn

演題番号 : P17-7

Withdrawn

Phase II prospective randomised trial comparing biweekly S-1 pluspaclitaxel with biweekly S-1 plus oxaliplatin for patients with advanced gastric cancer

演題番号 : P17-8

Mao Chen Y.:1、Jiang Hai P.:1、Wang Yao:2、Zhang Xiao C.:1、Zheng Yu L.:1、Deng Jing:1、Shi Gen M.:1、Teng Li S.:3、Xu Nong:1

1:Department of Medical Oncology, University of Zhejiang,The first affiliated hospital, School of medicine、2:Department of Medical Oncology, University of Fujian Medicine,The Union Hospital、3:Department of Oncological Surgery, University of Zhejiang,The first affiliated hospital, School of medicine

Phase II prospective randomised trial comparing biweekly S-1 pluspaclitaxel with biweekly S-1 plus oxaliplatin for patients with advanced gastric cancer

Involvement of exogenous factors in peritoneal metastaisis of gastric cancer

演題番号 : P17-9

Arita Tomohiro:1、Ichikawa Daisuke:1、Konishi Hirotaka:1、Komatsu Shuhei:1、Shiozaki Atsushi:1、Kosuga Toshiyuki:1、Shoda Katsutoshi:1、Morimura Ryo:1、Murayama Yasutoshi:1、Ikoma Hisashi:1、Kuriu Yoshiaki:1、Nakanishi Masayoshi:1、Fujiwara Hitoshi:1、Okamoto Kazuma:1、Otsuji Eigo:1

1:digestive surgery, Kyoto Prefectural University of Medicine

Involvement of exogenous factors in peritoneal metastaisis of gastric cancer

The impact of postoperative infectious complication in long-term outcome of patients with gastric cancer

演題番号 : P17-10

Sakurai Katsunobu:1、Tamura Tatsuro:1、Nagahara Hisashi:1、Kimura Kenjiro:1、Toyokawa Takahiro:1、Amano Ryosuke:1、Kubo Naoshi:1、Tanaka Hiroaki:1、Muguruma Kazuya:1、Yashiro Masakazu:1、Maeda Kiyoshi:1、Ohira Masaichi:1、Hirakawa Kosei:1

1:Surgical Oncology, Medical School, Osaka City University

The impact of postoperative infectious complication in long-term outcome of patients with gastric cancer

KIT and PDGFRA mutations of gastrointestinal stromal tumor

演題番号 : P17-11

Takahashi Tsuyoshi:1、Hirota Seiichi:2、Nishida Toshirou:3、Miyazaki Yasuhiro:1、Makino Tomoki:1、Kurokawa Yukinori:1、Yamasaki Makoto:1、Nakajima Kiyokazu:1、Takiguchi Syuji:1、Mori Masaki:1、Doki Yuichiro:1

1:surgery, Graduate School of Medicine, Osaka University、2:Department of Surgical Pathology, College Hospital(Nishinomiya), Hyogo College Of Medicine、3:Department of Surgery, National Cancer Center Hospital East

KIT and PDGFRA mutations of gastrointestinal stromal tumor

The Aurora-A inhibitors Alisertib and MK-5108 inhibit tumor progression by targeting different mechanisms

演題番号 : P17-12

Lin Wenhsin:1、Chen Yu-hsin:1、Lin Wen-hsing:1、Chang Chun-ping:1、Hsieh Hsing-pan:1、Chi Ya-hui:1

1:Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes

The Aurora-A inhibitors Alisertib and MK-5108 inhibit tumor progression by targeting different mechanisms